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Abstract: In this study, four major muscles acting on the scapula were investigated in patients who
had been treated in the last six years for unilateral carcinoma of the breast. Muscle activity was
assessed by electromyography during abduction and adduction of the affected and unaffected arms.
The main principal aim of the study was to compare shoulder muscle activity in the affected and
unaffected shoulder during elevation of the arm. A multivariate linear mixed model was introduced
and applied to address the principal aims. The result of fitting this model to the data shows a huge
improvement as compared to the alternatives.
Keywords: multivariate linear mixed model; correlated random effects; autoregressive of order one
1. Introduction
Wide local excision (WLE) with adjuvant radiotherapy is the standard treatment of breast
cancer. However, despite the use of less extensive surgery, there is still morbidity affecting the
shoulder [1–3]. Local radiotherapy has several known effects on lung parenchyma, vascular and
connective tissues [4–6]. Findings with respect to the latter suggest that thickening of the tissues may
restrict movement of surrounding areolar tissues held within fascial planes. This limited ability to
expand together with ischaemia due to changes in the vascular network could have an effect on the
efficacy of muscle contraction [7–9].
Thus far, the exact nature of shoulder morbidity and its relationship to pain has only been
described in terms of glenohumeral movement; ignoring the critical effect of scapulo-thoracic motions.
Scapular movements are a product of the delicate inter-play between the rotator cuff muscles; thus,
deficiency in one can alter all movements due to associations. The pattern of these associations is not
known and has been investigated here.
Scapular movements such as abduction, adduction, anterior/posterior tilt, and medial/lateral
rotations are a product of the delicate inter-play between the rotator cuff muscles. Deficiency in
one may change all other movements. The pattern of these associations is not known and needs to
be investigated.
Four muscles (pectoralis major, serratus anterior, upper trapezius and rhomboid major) acting
on the scapula were investigated in patients who had been treated in the last six years for unilateral
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carcinoma of the breast. Muscle activity was assessed by electromyography (EMG) during abduction
and adduction of the ipsilateral (affected) and contralateral (unaffected) sides.
The principal aims of the study were:
(1) to compare shoulder muscle activity in the affected and unaffected shoulder during elevation of
the arm;
(2) to explore the relationship between any observed differences in muscle activity and patients
report of pain and dysfunction;
(3) to explore the relationship between any observed differences in muscle activity and key
clinical variables.
Section 2 introduces the collected data set and its procedure. In Section 3, the multivariate linear
mixed models are described which address the above principal aims. Section 4 presents the results of
the fit of the model to the data. In Section 5, some final conclusions and a discussion of future analyses
are given.
2. Data Set
Two hundred and two patients who had been treated from 2005 to 2010 for unilateral carcinoma
of the breast were included in a shoulder morbidity study. The measurement procedure is detailed
in our previous work [10]. Patients with any previous history of shoulder or neck problems in either
arm were excluded from the study. Humeral elevation in degrees was measured using the Polhemus
Fastrak™ motion analysis system, and concurrent EMG readings were taken at 10˝ increments of
humeral elevation of each shoulder for each patient. The average of three EMG readings at each
elevation point was taken as a response (dependent) variable for each patient.
All patients filled in a Shoulder Pain and Disability Index (SPADI) questionnaire immediately
prior to data collection. The SPADI questionnaire is a known and valid measure of pain and disability
for shoulder dysfunction with high levels of sensitivity and reliability [11], it is scored on a visual
analogue scale with 13 items (five for pain and eight for disability). All subjects gave their informed
consent for inclusion before they participated in the study. The study was conducted in accordance
with the Declaration of Helsinki, and the protocol was approved by Oxford Brookes University ethics
committee (HREC no: A02,064)
Pain scores range from a minimum of 0 to a maximum of 500 mm and for disability 0 to 800 mm,
where 0 represents no symptoms of pain or disability. Figure 1 represents the distribution of pain
and disability scores. Given the skewness of these distributions, each variable is log-transformed in
subsequent analyses.
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Key clinical variables include: affected side, dominant hand, degree of arm elevation, treatment
protocol (Wide Local Excision (WLE) or other), duration after surgery in days, age in years,
physiotherapy and exercise level on affected side, receiving chemotherapy, and the Shoulder Pain and
Disability Index [10].
Bilateral EMG measurements of the four shoulder muscles were taken for each patient.
Each muscle activity is recorded in millivolts (mV) at 10˝ increments of humeral elevation during
upward and downward arm movement. At each increment point, for each shoulder and each
movement, four EMG measures were obtained (one for each of the four muscles), creating potentially
a correlated or multivariate response structure. Incremental measurements at different arm elevations
per muscle created a multivariate response structure that can also be regarded as “repeated measures”
dimension of the data. Summarised, four correlated, repeatedly measured responses for each shoulder
and each movement were generated. In Figure 2, typical observations of a patient are given, for
humeral elevation between 10˝ and 150˝, this figure represents the observations for an upward arm
movement of the left arm. This graph clearly shows that the EMG reading at each given point very
much depends on the previous reading within the same movement. Hence, this fact should be
implemented in the modelling strategy in Section 3.
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3. Statistical Hypotheses Testing and Statistical Modelling
3.1. Statistical Test of Clinical Hypotheses
Shamley et al. previously demonstrated [10] that the activities of muscles controlling the
movement of the scapula are linked; if one muscle is ompromised, then other uscles might become
more acti e to compen ate for th lost movement. How er, muscle activity can be influenced by
several demographic (age, dominance, gender) and clinical (pain, radiotherapy, chemotherapy, etc.)
variables. In this study, we are interested to explore the previous findings in detail and describe the
rationale of whether the clinical variables have the same effect on all muscles, or whether the effect
of these variables is different for different muscles under different conditions. Hence, an advanced
joint multivariate approach must be implemented to take these associations into consideration whilst
investigating the following four main null hypotheses.
Int. J. Environ. Res. Public Health 2016, 13, 274 4 of 13
H01: The altered muscle activity is not associated with the patient’s report of pain and dysfunction;
H02: Clinical risk factors have no effect on the activities of the muscles;
H03: The effect of clinical risk factors is the same on the affected arm as with that on the
unaffected arm.
H04: The activity of the four key muscles acting at the scapula on the affected arm is the same as
from those acting on the unaffected arm.
3.2. The Multivariate Linear Mixed Model
Let Yiksm denote the ni ˆ 1 vector of EMG readings at different humeral elevation points from
the ith patient (i = 1, . . . , N), ni is the number of elevation points for that patient on the kth muscle
(k = 1, . . . , 4), of the affected arm (s = 1) or unaffected arm (s = 2) during upward (m = 1) or downward
(m = 2) movements.
We assume for the ni measurements, Yiksm, a multivariate normal distribution over the elevations.
It is in fact the usual multivariate multiple regression, i.e.,:
Yiksm „ N pXiksmβksm,Σkq (1)
where Xiksm is a ni ˆ p matrix of covariates (p is the number of covariates), βksm is a p ˆ 1 vector of
regression coefficients and Σk is a ni ˆ ni covariance matrix.
Obviously, when the humeral elevations are closer, the correlation should be stronger, therefore,
after testing a few other correlation structures, we sensibly assumed an autoregressive structure of
order one, i.e., AR(1) for Σk, i.e.,
Σk “ σ2k
¨˚
˚˚˚˚
˝
1 ρk ρ2k ¨¨ ρni´1k
ρk 1 ρk ρ2k ¨¨
ρ2k ρk 1 ρk ¨¨
: : : : :
ρ
ni´1
k ¨¨ ¨ ¨ ¨ ρk 1
‹˛‹‹‹‹‚ (2)
A simplifying assumption could be to assume that the responses are independent among patients
and muscles, that is
Yik “
»———–
Yik11
Yik12
Yik21
Yik22
fiffiffiffifl „ N
»———–
¨˚
˚˝˚ Xik11βk11Xik12βk12
Xik21βk21
Xik22βk22
‹˛‹‹‚,Σkk “
¨˚
˚˝˚ Σk 0 0 00 Σk 0 0
0 0 Σk 0
0 0 0 Σk
‹˛‹‹‚
fiffiffiffifl (3)
It is generally unrealistic to assume that all important risk factors (covariates) are measured
and included in the model explanatory matrix (Xiksm). The unobserved or unmeasured risk factors
of a muscle, which are usually known as the “unobserved muscle’s specific effect”, causes the
measurements of a muscle to be more correlated. To improve Model (3), one could introduce a “muscle
specific effect” or random effect into the model. This term usually is known as frailty, so that,
conditional on this muscle’s specific effect, νik, we can assume
Yik|vk „ N pXikβk ` vik,Σkkq (4)
with, Xik, the stacked design matrix XTik “
“
XTik11X
T
ik12X
T
ik21X
T
ik22
‰
and βTk “
“
βTk11, β
T
k12, β
T
k21, β
T
k22
‰
.
Coull and Agresti [12] presented similar models for multivariate binomial logit-normal.
Fieuws et al. [13] discussed similar models in more detail.
Furthermore, we assumed that the frailty terms of different muscles are correlated. That is, we
assumed that the vector of frailty terms νTi “ pνi1, νi2, νi3, νi4q has the following distribution:
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νi “
»———–
νi1
νi2
νi3
νi4
fiffiffiffifl „ N
»———–
¨˚
˚˝˚ 00
0
0
‹˛‹‹‚, D “
¨˚
˚˝˚ d11 d12 d13 d14d12 d22 d23 d24
d13 d23 d33 d34
d14 d24 d34 d44
‹˛‹‹‚
fiffiffiffifl . (5)
We assume that the joint model of YTi “ pYi1,Yi2,Yi3,Yi4q follows a conditional multivariate
normal distribution
Yi|νi „ N
»———–
¨˚
˚˝˚ Xi1β1 ` νi1,Xi2β2 ` νi2,
Xi3β3 ` νi3,
Xi4β4 ` νi4,
‹˛‹‹‚,Σ “
¨˚
˚˝˚ Σ1 0 0 00 Σ2 0 0
0 0 Σ3 0
0 0 0 Σ4
‹˛‹‹‚
fiffiffiffifl (6)
with the normal distribution of the frailty vector which adds the covariance structure to the frailties
across muscles. The joint model defined by Model (6) is a multivariate linear mixed model with
multivariate random effects νi.
As for the univariate linear mixed model with a univariate normal random effect, the marginal
likelihood in Model (6) is also analytically tractable. We used SAS™ [14] 9.2, PROC MIXED (SAS, Cary,
NC, USA) to estimate the model parameters.
In this model, the correlation structure among the muscles is presented by the correlation structure
among their specific frailties given by the variance-covariance matrix (D); if the muscles are not
significantly correlated, all off-diagonal entities in the variance-covariance matrix D will be zero.
Significant non-zero off-diagonal entities of variance-covariance matrix D are showing the correlations
among the muscles.
4. Empirical Results
4.1. Model Comparison
Table 1 presents the result of analyzing the natural log transformation of EMG activities of each
muscle using Model (3), i.e., a multivariate normal distribution for ln(emgiksm) = Yiksm with block
diagonal variance-covariance matrix of Σk. The likelihood ratio test suggests that the effect of arm
movement (MOVE_UP/MOVE_DOWN) is best presented by a dummy variable indicating different
intercepts for the upward and downward movement. Interactions between arm movements with all
other clinical risk factors (covariates) were not collectively significant at the 5% level.
Contrariwise, the effect of affected shoulder and unaffected shoulder cannot be modelled by
considering only different intercepts for affected/unaffected shoulder. This is due to the fact that some
of the risk factors are specific to the affected shoulder, such as physiotherapy and exercise. This implies
that the effect of clinical risk factors might well be different on the affected shoulder compared to
the unaffected shoulder. Therefore, a full interaction model (all main effects and all interactions)
initially was employed to assess the effects of the affected shoulder on all clinical risk factors; the
highly insignificant interactions were subsequently dropped from the model. The likelihood ratio test
suggests that the included interactions are highly significant (change in deviance of 717.2 for 32 degrees
of freedom).
The values in bold correspond to significant effects (at the 5% level) for each muscle. The last
column (“p-value”) indicates whether the clinical risk factor is collectively (the effect on all four muscles
collectively with four degrees of freedom) significant or not.
A significant value for the interaction terms shows that, over and above the overall effect of the
clinical risk factor on electrical activity of the muscles, the effect of clinical risk factor on the affected
side is different to the unaffected side. The autoregressive correlation (ρk) and the variance of each
muscle (σ2k ) are also presented.
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Table 1. Results of the analysis using a multivariate normal distribution with autoregressive of order
one (AR(1)) structure for Σk.
Clinical Measures
Parameter Estimates p-Value
Ln(PM) Ln(UT) Ln(SA) Ln(RH) Overall Effect
Intercept 2.9812 3.07 2.7905 2.1944 <0.0001
Humeral elevation ˆ 100 0.5053 0.5868 0.8403 0.7097 <0.0001
Move up 0.1175 0.287 0.1286 0.1746 <.0001
Affected ´0.1897 0.02896 0.4124 ´0.0995 0.1855
Handleft 0.2908 0.1677 0.1959 0.1686 <0.0001
Dominant 0.07338 0.1233 0.07865 0.07744 0.4888
Agex100 ´0.00037 0.4736 ´0.503 0.4888 0.0386
Duration ˆ 100 ´0.01 0.0024 0.0119 0.0125 0.0286
Spadipai ˆ 100 ´0.146 ´0.156 ´0.061 ´0.095 0.0005
Spadidis ˆ 100 0.0591 0.0726 0.0707 ´0.042 0.1284
Wle ´0.2556 ´0.1913 ´0.2544 ´0.2267 <0.0001
Chemocat ´0.1107 ´0.0803 ´0.4658 ´0.1233 <0.0001
Inter_humeral elevation * ˆ 100 0.0161 0.0837 0.019 0.1194 0.2037
Inter_dominant * ´0.2211 ´0.1212 ´0.3452 ´0.2614 <0.0001
Inter_duration * ˆ 100 0.0037 ´0.004 ´0.021 ´0.007 0.1410
Inter_spadipai * ˆ 100 0.1083 0.1046 ´0.051 0.0948 0.0239
Exercise 6 m ** ´0.00577 ´0.0644 ´0.05941 0.01678 0.0349
Exercise now ** 0.06808 0.05504 0.08655 0.01458 <0.0001
Physio now ** 0.307 0.5523 0.1583 0.3082 0.1207
Physio ever ** ´0.01245 ´0.0663 0.1235 ´0.1439 0.4765
ρ 0.89 0.92 0.90 0.91 N/A
σ2 0.62 0.73 0.61 0.63 N/A
–2 log likelihood of the model with interaction terms
–2 log likelihood of the model without interaction
29,181.2
29,898.4
* Interaction with affected side, ** Only on affected side.
The result of fitting a multivariate normally distributed model with AR(1) structure for Σk,
presented in Table 1, controls the autoregressive structure of the measurements. The high positive
value of ρ shows that the electrical activities are more alike at humeral elevation angles that are
closer together.
This model not only ignores associations among the four muscles but also ignores any possible
associations between measurements of the same muscle, i.e., affected/unaffected shoulders and
downwards/upwards movement. In other words, this model assumes independence between the four
muscles and between all observations of the same muscle at the same humeral elevation. This is not
a realistic assumption as the four muscles are from the same individual and are likely to be correlated,
and all measurements of the same muscle at the same humeral elevation are also likely to be correlated
as they are from the same muscle. Table 2 is the result of fitting a univariate linear mixed Model (4)
with independent random intercept νk across muscles and residual block diagonal variance-covariance
matrix with blocks Σk assumed to follow the auto-regressive process of order one. Model (4) controls
the association between the measurements of the same muscles at the same humeral elevation point
by including a muscle specific random effect into the model.
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Table 2. Result of the analysis using univariate Linear Mixed Model with AR(1) structure for Σk.
Clinical Measures
Parameter Estimates p-Value
Ln(PM) Ln(UT) Ln(SA) Ln(RH) Overall Effect
Intercept 3.0631 3.1468 2.8339 2.2456 <0.0001
Humeral elevation ˆ 100 0.4999 0.5733 0.8288 0.6937 <0.0001
Move up 0.1357 0.2985 0.136 0.2008 <0.0001
Affected –0.06145 0.07579 0.5562 0.1457 0.0113
Handleft 0.2825 0.154 0.199 0.1627 <0.0001
Dominant 0.07379 0.1044 0.07393 0.07766 0.6258
Agex100 –0.088 0.4317 ´0.542 0.4361 0.5757
Duration ˆ 100 –0.011 0.0022 0.0113 0.0119 0.2323
Spadipai ˆ 100 –0.147 –0.155 –0.063 –0.104 0.1053
Spadidis ˆ 100 0.0532 0.0676 0.0589 –0.035 0.8000
Wle –0.2831 ´0.199 ´0.2626 –0.2262 <0.0001
Chemocat –0.1611 –0.1034 –0.4759 ´0.1365 0.0231
Inter_humeral elevation * ˆ 100 0.0029 0.0774 0.0047 0.1091 0.1146
Inter_dominant * –0.2326 –0.1192 –0.3466 –0.2746 0.0654
Inter_duration * ˆ 100 0.0022 –0.007 –0.024 ´0.011 <0.0001
Inter_spadipai * ˆ 100 0.1042 0.1195 ´0.023 0.1221 <0.0001
Exercise 6 m ** –0.02449 –0.04658 –0.05968 0.003809 0.0142
Exercise now ** 0.06914 0.01997 0.05287 –0.03337 <0.0001
Physio now ** 0.01201 0.4788 0.1107 0.5951 0.0060
Physio ever ** 0.002231 –0.1651 0.01827 –0.2481 0.0163
ρ 0.79 0.85 0.82 0.80 N/A
σ2 0.31 0.37 0.33 0.29 N/A
Random effect variance 0.33 0.38 0.28 0.35 N/A
–2 log likelihood of the model with interaction terms
–2 log likelihood of the model without interaction
27,645.1
27,862.8
* Interaction with affected side, ** Only on affected side.
This model suggests that humeral elevation of the arm, the upwards move, affected side and left
shoulder will increase the electrical activity generally for all four muscles irrespective of which side is
affected, whilst treatment with wide local excision and receiving chemotherapy are associated with
generally decreased electrical activity.
Interaction analysis suggests that the electrical activity is significantly different for duration
after surgery and SPADI pain. Doing exercise and having physiotherapy on the affected shoulder
are significantly associated with electrical activity of the affected muscles. The deviance (´2 ˆ log
likelihood) for this model is 27,645.1. The change in deviance compared to Model (3) is 1536.1 for four
degrees of freedom (p-value < 0.0001), which is highly statistically significant.
Univariate Linear Mixed Model with AR(1) structure for Σk controls the autoregressive structure
of the measurements and accounts for possible associations between measurements of the same muscle
at the same elevation point. The disadvantage of Model (4) is that it ignores any possible associations
among the four muscles within patients. Table 3 is the result of fitting a full multivariate linear mixed
model with AR(1) structure for Σk given in Model (6).
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Table 3. Result of the analysis using multivariate Linear Mixed Model with AR(1) structure for Σk.
Clinical Measures
Parameter Estimates p-Value
Ln(PM) Ln(UT) Ln(SA) Ln(RH) Overall Effect
Intercept 3.0662 3.1566 2.8413 2.2559 <0.0001
Humeral elevation ˆ 100 0.5012 0.5761 0.8314 0.694 <0.0001
Move_up 0.1357 0.299 0.1362 0.201 <0.0001
Affected –0.03653 0.1271 0.5837 0.1368 0.0054
Handleft 0.2837 0.1537 0.1983 0.1608 <0.0001
Dominant 0.07391 0.1057 0.07586 0.07687 0.8796
Age ˆ 100 –0.093 0.4211 –0.549 0.4292 0.1775
Duration ˆ 100 –0.011 0.0021 0.0112 0.0119 0.0227
Spadipai ˆ 100 –0.148 –0.155 –0.064 –0.103 0.4220
Spadidis ˆ 100 0.0533 0.0679 0.0604 –0.037 0.5270
Wle –0.283 –0.2028 –0.2668 –0.2306 0.0272
Chemocat –0.1598 –0.1078 –0.4812 –0.1446 0.0205
Inter_humeral elevation * ˆ 100 5.07E-04 0.0737 0.0036 0.1096 0.1219
Inter_dominant * –0.2347 –0.1247 –0.3505 –0.2764 0.2958
Inter_duration * ˆ 100 0.0015 ´0.008 –0.024 –0.011 <0.0001
Inter_spadipai * ˆ 100 0.1115 0.1211 –0.023 0.1212 <0.0001
Exercise 6 m ** –0.02175 –0.05333 –0.06286 0.006382 0.0049
Exercise now ** 0.05879 0.01727 0.05089 –0.03237 <0.0001
Physio now ** 0.08553 0.4907 0.1158 0.5001 0.0177
Physio ever ** –0.0337 –0.1669 0.02314 –0.2484 0.0121
ρ 0.79 0.85 0.82 0.80 N/A
σ2 0.31 0.37 0.33 0.29 N/A
Random effect variance 0.33 0.38 0.29 0.35 N/A
–2 log likelihood of the model with interaction terms
–2 log likelihood of the model without interaction
26,833.2
27,522.8
* Interaction with affected side, ** Only on affected side.
The result of fitting a full multivariate Linear Mixed Model with AR(1) structure for Σk, as
expected, is almost similar to that of Model (4). This model suggests that humeral elevation of
the arm, the upwards move, affected side, left shoulder and longer duration from the surgery will
increase the electrical activity generally for all four muscles irrespective of the side affected—whilst
treatment with wide local excision and receiving chemotherapy are associated with generally decreased
electrical activity
Interaction analysis suggests that electrical activity is significantly different for duration after
surgery and SPADI pain. Once again, doing exercise and having physiotherapy on the affected shoulder
are significantly associated with electrical activity of the affected muscles. SPADI pain increases the
muscle activity in the affected arm, but the affected arm slightly dilutes the positive effect of duration
since surgery on the muscle activity. The deviance for this model is 26833.2. The change in deviance
compared to Model (4) is 811.9 for six degrees of freedom, and, compared to Model (3), the change in
deviance is 2348 for 10 degrees of freedom. Both suggest statistically significant improvement (both
p-values < 0.0001) in model fitting.
Hence, using a multivariate normal distribution for natural log of muscle activities with AR(1)
structure for Σk, for each muscle and ignoring the existing associations between the measurements
leads to unrealistic inferences for important clinical variables.
Applying a univariate Linear Mixed Model with AR(1) structure for Σk (4) while ignoring the
associations between muscle specific effects leads to clinically much more sensible parameter estimates.
Subsequently, comparing the likelihoods of Models (3) and (4) confirms the presence of strong muscle
specific effects.
A full multivariate Linear Mixed Model with AR(1) structure for Σk (6) assesses the presence of
significant association between muscle-specific random effects. A deviance difference of 811.9 for six
degrees of freedom suggests the use of a joint multivariate linear mixed model with residual block
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diagonal variance-covariance matrix, which assumed to following auto-regressive process of order
one, is more appropriate.
In this model, the associations between measurements of the same movement at different elevation
points is given by ρ for each muscle. The estimated value of ρ is about 0.8, which shows a strong
association between measurements of the same movement. However, the associations between muscles
where modelled via their unobserved specific random effects. The estimated variance-covariance
matrix of this association is given in the following matrix Dˆ:
Dˆ “
¨˚
˚˝˚ 0.330.23 0.38
0.21 0.18 0.29
0.24 0.25 0.22 0.35
‹˛‹‹‚ (7)
A likelihood ratio test comparing Models (4) and (6) shows that the associations between muscles
are very important and cannot be ignored. The estimated variance-covariance matrix Dˆ indicates that
all estimated off-diagonal entities are positive, which demonstrates that all correlations among the
muscles are significantly positive.
4.2. Statistical Inference of Clinical Hypotheses
The result of Model (6), which is presented in Table 3, can be explored and refitted to assess the
main clinical hypotheses.
H01: The activity of four key muscles acting at the scapula on the affected arm is not different to
those acting on the unaffected arm.
The null hypothesis H01 should be rejected as the activity of four key muscles acting at the scapula
on the affected arm is significantly different to the unaffected arm. The gain in deviance between
models with and without affected side interactions is 689.6 for 16 degrees of freedom returning
a p-value < 0.0001, highly statistically significant.
H02: Altered muscle activity is not associated with patients’ report of pain or dysfunction.
SPADI pain has a significant effect on activity of the affected arm p-value < 0.0001); however,
report of pain and dysfunction had no significant effect in general.
H03: Clinical risk factors have no significant effect on the activity of muscles.
Clinical risk factors have a significant effect on muscle activities. For instance, WLE treatment
(p-value = 0.027) and chemotherapy (p-value = 0.021), compared to their alternatives, have adverse
effects on all muscle activities.
H04: The effects of clinical risk factors are not different on the affected arm as compared to the
unaffected arm. The effects of clinical risk factors on muscle activity are different on the affected arm
compared to the unaffected arm. For example, reports of pain and dysfunction (SPADI pain) had
no significant effect on the unaffected arm (p-value = 0.422), but increasing SPADI pain is associated
with increased muscle activity in the affected arm (p-value < 0.0001). Duration since surgery is
associated with decreased muscle activity in the affected arm as compared to the unaffected arm
(p-value < 0.0001).
4.3. Checking Model Assumptions
Figure 3 is the result of a diagnostic analysis, and it shows the standardised residuals of the full
multivariate mixed linear model with AR(1) variance-covariance structure. It is clear that most of the
standardised residuals have an absolute value of less than 2.0, which could have easily occurred by
chance. It is expected that 5% of standardised residuals should be greater than 2.0 in absolute value
according to expected standard normal distribution of the standardised residuals. Hence, Figure 3
does not show any serious diversion from normality for residuals of the implemented multivariate
linear mixed model given by Model (6).
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Figure 4 may potentially detect influential observations. Here, residuals are presented similar to
the standardised residuals except that they are calculated after deleting the ith observation. In other
words, the figure shows the difference between the observed response values and the predicted
response values excluding the ith observation from the regression.
The comparison between the two figures does not suggest any major influential observation that
if removed has significant effect on parameter estimates.
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5. Discussions
Our results demonstrated that the affecte side is significantly different in terms of muscle
activity th n the unaffected side. This is un erstandable given the n ture of the disease and treatment.
The results of our model also demonstrate, however, several other important points.
Firstly, with respect to personal factors, only pain appears to play a significant role. Whilst no
effect was observed with respect to SPADI pain in the unaffected arm, it was associated with increased
muscle activity in the affected arm. This phenomenon has been previously reported and is hypothesised
Int. J. Environ. Res. Public Health 2016, 13, 274 11 of 13
to be a functional adaptation in order to limit movements of the painful muscle, hence reduce overall
pain [15].
Hand dominance had no significant effect on muscle activity, regardless of the operated side
correlating well with other studies demonstrating either no difference in female subjects [16] or only
significance in a few movements, primarily the flexion [17–19]. Still independent of the operative
side, there is also greater activation and activity in shoulder muscles during abduction of the arm
compared to adduction, with the magnitude of activity being proportional to the extent of abduction.
The significant difference between abduction and adduction as displayed by the model is naturally
expected due to the nature of gravity assisting adduction and thus activating of fewer muscle spindles.
We hypothesise that if adduction was performed against resistance such as to simulate the force of
gravity which muscles experience during abduction, then activity would be similar. The significance
of these findings between healthy volunteers and breast cancer survivors should be assessed in
a case-control study.
With respect to clinical factors, previous work had already demonstrated that surgical breast
cancer treatment resulted in shoulder morbidity [10], with recent work also showing mastectomy
causing greater degrees than WLE [20]. This study of WLE, controlling for chemotherapy and
radiotherapy effects, also demonstrated a significant adverse effect on all muscles independent of the
affected side, similar to previously reported results.
The effects of various variables on muscles are summarized in Table 4. The effect of time since
surgery on muscle activity was not significant per muscle, although, overall, its effect was significant.
The effect of chemotherapy similarly shows significant reduction in overall muscle activity on the
ipsilateral side, although, individually, the difference was only significant for the serratus anterior.
Chemotherapy induced peripheral neuropathy (CIPN) is a well-known complication of adjuvant
therapy, and its incidence is closely linked to the agents used. Although primarily a sensory neuropathy,
motor complications have also been reported [21] with greater impact on quality of life [22]. Taxanes,
prolific agents used in breast cancer treatment [23], have been implicated in reduced compound muscle
action potentials and myopathy, although less frequently than their sensory effects [24]. With respect
to the observed difference on the contralateral side with serratus anterior, we could hypothesise that,
due to the length of the long thoracic nerve, it may be more at risk from the neurotoxic effects of
the chemotherapy agents. This is not without precedence, as the sural nerve, another similarly long
nerve, has been reported as being particularly at risk of CIPN with platinum and paclitaxel based
compounds [25].
Table 4. Factors that significantly affect muscle activity, irrespective of affected shoulder.
Variable
EMG Effect (Significant)
Pectoralis Major Upper Trapezius Serratus Anterior Rhomboid
Humeral Elevation Ò * Ò * Ò * Ò *
Left vs. Right Shoulder Ò * Ò * Ò * Ò *
Time Since Surgery
(DURATION) Ó Ò Ò Ò
WLE (vs. Other
Treatment Modalities) Ó * Ó * Ó * Ó *
Chemotherapy Ó Ó Ó * Ó
* indicates, significant at the 5% level.
With respect to rehabilitation, our model indicates that pain, physiotherapy and exercise result in
an overall significant increase in muscle activity on the affected shoulder (Table 5). Specifically, exercise
results in independent increases for the pectoralis major, upper trapezius and serratus anterior whilst
physiotherapy results in similar findings for the latter two aforementioned muscles. With respect to
the affected side, only our findings are summarised in Table 5.
Int. J. Environ. Res. Public Health 2016, 13, 274 12 of 13
Table 5. Significant factors affecting muscle activity on the affected shoulder as compared to the
unaffected shoulder.
Variable
EMG Effect (Significant)
Pectoralis Major Upper Trapezius Serratus Anterior Rhomboid
Increasing Pain Score Ò * Ò * Ó Ò *
Exercise Last 6 Months Ó Ó * Ó * Ò
Current Exercise Ò * Ò Ò * Ó *
Current Physiotherapy Ò Ò * Ò Ò *
Time Since Surgery Ò Ó Ó * Ó *
Physiotherapy, either currently or at any point, was shown to improve muscle activity on the
affected shoulder significantly. Multiple previous studies have demonstrated the beneficial effect
of physiotherapy on shoulder function; maintenance of movement ranges, reduced pain, improved
muscle strength and overall better quality of life are all reported [1,26,27].
6. Conclusions
Shoulder EMG activity and, therefore, muscle activation depends on both clinical and personal
variables. Clinically the use of chemotherapy, WLE and time since surgery all decrease muscle
activation, whilst physiotherapy increases it. Pain, a personal subjective influence, serves to increase
muscle activation and is likely to limit movement and prevent further pain. This work builds on
previously published data and offers new insights into the variables that affect shoulder morbidity
with an effective model. This study further adds to the understanding of modelling multi-dimensional
data and illustrates the risk of ignoring potential associations in the data structure. Several modelling
approaches were discussed and compared, and the more suitable analysis method was identified and
applied to the data.
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